beta-lactamase-IN-1 |
| Katalog-Nr.GC33078 |
Beta-Lactamase-IN-1 ist ein Inhibitor von β-Lactamase, extrahiert aus dem Patent WO2016027249A1, Seite 77.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1075237-97-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Treating Neisseria gonorrhoeae infection which comprises administering to a subject in need thereof novel Tricyclic nitrogen containing compounds and corresponding pharmaceutical compositions as described herein.
[1]. PCT Int. Appl. (2016), WO 2016027249 A1 20160225.
Review for beta-lactamase-IN-1
Average Rating: 5 (Based on Reviews and 38 reference(s) in Google Scholar.)
Review for beta-lactamase-IN-1
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *